HubMOL Hub Molecules of Metabolism and Signalling – Key regulators of Life
- Coordinator
- Universitetet I Tromsoe - Norges Arktiske Universitet, Norway
- Runs
- 1 January 2025 to 31 December 2028
- Status
- Running
- EU funding
- €4.2m
- Total cost
- —
- Partners
- 21 organisations in 8 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101168783
What the project is doing
In the project's own words, from its summary on CORDIS.
Metabolic disorders are a major burden on the European population and health care systems. Moreover, metabolic perturbations contribute substantially to other pathologies such as neurodegenerative disorders and cancer. The causes of metabolic dysregulation are manifold and lead to pathological shifts, often in response to imbalanced nutrition. Likewise, changes in metabolism affect signalling mechanisms and gene regulation, aggravating the pathology.
The mechanisms of this interdependence between metabolism and signalling are still not well understood. HubMOL will fill this knowledge gap and open new horizons by exploring the functional duality of a set of small molecules that are involved in all cellular functions - the Hub Molecules Of Life (HubMOLs) including ATP, SAM (S-adenosylmethionine) and the vitamin-derived cofactors, NAD, FAD, and CoA. They are key components of both metabolism and signalling networks and are interconnected, for example, through their participation in posttranslational protein modifications (PTMs).
The complexity of this emerging area requires interdisciplinary scientists equipped with comprehensive competences covering experimental, computational and systems biology as well as clinical medicine. Therefore, the main HubMOL goal is to provide world-class training in these areas to 16 DCs enabling them to establish fundamentally new insights into cofactor biology and lay the ground for patient-tailored vitamin supplementation concepts.
The strategic exposure of the 16 young researchers to leading European academic institutions, companies and clinical environments combined with systematic training in entrepreneurship and transferable skills will strongly improve their employability for positions in both private and public sectors. HubMOL will impact patients and society by developing therapies for metabolic and regulatory imbalances based on hub molecule biology.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitetet I Tromsoe - Norges Arktiske Universitet | Tromso | Norway | Coordinator |
| Universitaet Innsbruck | Innsbruck | Austria | Participant |
| Waters Ges.m.b.H. | Wien | Austria | Associatedpartner |
| Societe Des Produits Nestle SA | Vevey | Switzerland | Associatedpartner |
| Beilstein-Institut zur Förderung der Chemischen Wissenschaften | Frankfurt Am Main | Germany | Associatedpartner |
| Eisbach Bio GmbH | Planegg- Martinsried | Germany | Participant |
| Ludwig-Maximilians-Universitaet Muenchen | Planegg | Germany | Associatedpartner |
| Universitaet Leipzig | Leipzig | Germany | Participant |
| Universitaetsklinikum Essen | Essen | Germany | Participant |
| Kobenhavns Universitet | Kobenhavn | Denmark | Participant |
| Ms-Omics Aps | Vedaek | Denmark | Participant |
| Fundacio Institut De Recerca Contra La Leucemia Josep Carreras | Badalona | Spain | Participant |
| Universitat Autonoma De Barcelona | Cerdanyola Del Valles | Spain | Associatedpartner |
| Consiglio Nazionale Delle Ricerche | Roma | Italy | Participant |
| Universita Degli Studi Della Campania Luigi Vanvitelli | Caserta | Italy | Associatedpartner |
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Participant |
| Mimetas BV | Leiden | Netherlands | Participant |
| Rijksuniversiteit Groningen | Groningen | Netherlands | Associatedpartner |
| Kingman Filmproduksjon | Norway | Associatedpartner | |
| Simula Research Laboratory AS | Oslo | Norway | Participant |
| Universitetet I Bergen | Bergen | Norway | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI